Propranolol impairs the closure of pressure ulcers in mice

Life Sciences

Volumn 100, Issue 2, 2014, Pages 138-146

  Assis De Brito, Thatiana L ^a   Monte Alto Costa, Andréa ^a   Romana Souza, Bruna ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Ischemia reperfusion injury; Pressure ulcer; Skin; Wound healing; Adrenoceptors

Indexed keywords

COLLAGEN; LEUKOCYTE ELASTASE; MACROPHAGE ELASTASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROPRANOLOL; TENASCIN; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; DECUBITUS; DRUG EFFECT; EPIDERMIS; EPITHELIZATION; EUTHANASIA; KERATINOCYTE; MALE; MYOFIBROBLAST; NONHUMAN; PROTEIN EXPRESSION; REPERFUSION INJURY; SCAR FORMATION; SKIN INJURY; TISSUE NECROSIS; WOUND CLOSURE; WOUND HEALING;

ANIMALIA; MUS;

DIAMINOBENZIDINE (PUBCHEM CID: 7071); FORMALIN (PUBCHEM CID: 712); HEMATOXYLIN (PUBCHEM CID: 442514); HYDROCHLORIC ACID (PUBCHEM CID: 313); ISCHEMIA-REPERFUSION INJURY; KETAMINE (PUBCHEM CID: 3821); METHANOL (PUBCHEM CID: 887); POLYACRYLAMIDE (PUBCHEM CID: 6579); PRESSURE ULCER; PROPRANOLOL HYDROCHLORIDE (PUBCHEM CID: 62882); SKIN; SODIUM DODECYLSULFATE (PUBCHEM CID: 3423265); SODIUM HYDROXIDE (PUBCHEM CID: 14798); SULFURIC ACID (PUBCHEM CID: 1118); WOUND HEALING; XYLAZINE (PUBCHEM CID: 5707); XYLENOL ORANGE (PUBCHEM CID: 16220156); Β-ADRENOCEPTORS;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOTTING, WESTERN; EPIDERMIS; HYDROXYPROLINE; IMMUNOENZYME TECHNIQUES; LIPID PEROXIDES; MALE; MICE; PRESSURE ULCER; PROPRANOLOL; REPERFUSION INJURY; SKIN; WOUND HEALING;

EID: 84897050040     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.02.007     Document Type: Article

References (60)

1. Altman JD, Trendelenburg AU, MacMillan L, Bernstein D, Limbird L, Starke K, et al. Abnormal regulation of the sympathetic nervous system in alpha2A-adrenergic receptor knockout mice. Mol Pharmacol 1999;56:154-61. (Pubitemid 29309824)
2. Anesini C, Borda E. Modulatory effect of the adrenergic system upon fibroblast proliferation: participation of beta 3-adrenoceptors. Auton Autacoid Pharmacol 2002;22: 177-86. (Pubitemid 36687568)
3. Baddeley AJ, Gundersen HJ, Cruz-Orive LM. Estimation of surface area from vertical sections. J Microsc 1986;142:259-76.
4. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen 2008;16:585-601.
5. Brum PC, Kosek J, Patterson A, Bernstein D, Kobilka B. Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice. Am J Physiol Heart Circ Physiol 2002;283:H1838-45. (Pubitemid 35217017)
6. Calvillo L, Spazzolini C, Vullo E, Insolia R, Crotti L, Schwartz PJ. Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients. Heart Rhythm 2014;11:126-32.
7. Cardoso JF, Souza BR, Amadeu TP, Valenca SS, Porto LC, Costa AM. Effects of cigarette smoke in mice wound healing is strain dependent. Toxicol Pathol 2007;35:890-6.
8. Chen X, Liu Y, Zhang X. Topical insulin application improves healing by regulating the wound inflammatory response. Wound Repair Regen 2012;20:425-34.
9. Cullum N, Nelson EA, Nixon J. Pressure ulcers. Clin Evid 2006;15:2592-606.
10. Dalkowski A, Fimmel S, Beutler C, Zouboulis ChC. Cryotherapy modifies synthetic activity and differentiation of keloidal fibroblasts in vitro. Exp Dermatol 2003;12:673-81. (Pubitemid 37270730)
11. Diegelmann RF. Excessive neutrophils characterize chronic pressure ulcers. Wound Repair Regen 2003;11:490-5. (Pubitemid 37467733)
12. Duell EA. Identifi cation of a beta 2-adrenergic receptor in mammalian epidermis. Biochem Pharmacol 1980;29:97-101. (Pubitemid 10212803)
13. Gabbiani G. Themyofibroblast: a key cell for wound healing and fibrocontractive diseases. Prog Clin Biol Res 1981;54:183-94.
14. Gomes A, Costa D, Lima JL, Fernandes E. Antioxidant activity of beta-blockers: an effect mediated by scavenging reactive oxygen and nitrogen species? Bioorg Med Chem 2006;14:4568-77. (Pubitemid 43728661)
15. Gundersen HJ, Bagger P, Bendtsen TF, Evans SM, Korbo L, Marcussen N, et al. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. Apmis 1988;96:857-81.
16. Hoffbrand BI. Peripheral skin necrosis complicating beta-blockade. BrMed J 1979;1:1082. (Pubitemid 9148532)
17. Kondo T, Ishida Y. Molecular pathology ofwound healing. Forensic Sci Int 2010;203:93-8.
18. Kosiak M. Etiology and pathology of ischemic ulcers. Arch Phys Med Rehabil 1959;40:62-9.
19. Leicht M, Greipel N, Zimmer H. Comitogenic effect of catecholamines on rat cardiac fibroblasts in culture. Cardiovasc Res 2000;48:274-84.
20. Lewis P. The essential action of propranolol in hypertension. Am J Med 1976;60:837-52.
21. Mackie EJ, Halfter W, Liverani D. Induction of tenascin in healing wounds. J Cell Biol 1988;107:2757-67. (Pubitemid 19019409)
22. Margolis DJ, Hoffstad O, Isseroff RR. Association between the use of beta-adrenergic receptor agents and the development of venous leg ulcers. Arch Dermatol 2007;143:1275-80. (Pubitemid 47607678)
23. McSwigan JD, Hanson DR, Lubiniecki A, Heston LL, Sheppard JR. Down syndrome fibroblasts are hyperresponsive to beta-adrenergic stimulation. Proc Natl Acad Sci U S A 1981;78:7670-3. (Pubitemid 12186623)
24. Mekkes JR, Loots MA, Van Der Wal AC, Bos JD. Causes, investigation and treatment of leg ulceration. Br J Dermatol 2003;148:388-401. (Pubitemid 36461316)
25. Mohammadi AA, Bakhshaeekia A, Alibeigi P, Hasheminasab MJ, Tolide-ei HR, Tavakkolian AR, et al. Efficacy of propranolol in wound healing for hospitalized burn patients. J Burn Care Res 2009;30:1013-7.
26. Mustoe T. Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy. Am J Surg 2004;187:65S-70S. (Pubitemid 38625990)
27. Nascimento AP, Costa AM. Overweight induced by high-fat diet delays rat cutaneous wound healing. Br J Nutr 2006;96:1069-77. (Pubitemid 46470170)
28. Nourooz-Zadeh J, Tajaddini-Sarmadi J, Wolff SP. Measurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem 1994;220:403-9.
29. Nwomeh BC, Liang HX, Cohen IK, Yager DR. MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers. J Surg Res 1999;81:189-95. (Pubitemid 29397810)
30. Peirce SM, Skalak TC, Rodeheaver GT. Ischemia-reperfusion injury in chronic pressure ulcer formation: a skin model in the rat. Wound Repair Regen 2000;8:68-76. (Pubitemid 30140801)
31. Pullar CE, Isseroff RR. Beta 2-adrenergic receptor activation delays dermal fibroblast-mediated contraction of collagen gels via a cAMP-dependent mechanism. Wound Repair Regen 2005;13:405-11. (Pubitemid 41060422)
32. Pullar CE, Isseroff RR. The beta 2-adrenergic receptor activates pro-migratory and pro-proliferative pathways in dermal fibroblasts via divergent mechanisms. J Cell Sci 2006;119:592-602.
33. Pullar CE, Chen J, Isseroff RR. PP2A activation by beta2-adrenergic receptor agonists: novel regulatory mechanism of keratinocyte migration. J Biol Chem 2003;278:22555-62. (Pubitemid 36830311)
34. Pullar CE, Grahn JC, Liu W, Isseroff RR. Beta2-adrenergic receptor activation delayswound healing. Faseb J 2006a;20:76-86. (Pubitemid 43100478)
35. Pullar CE, Rizzo A, Isseroff RR. Beta-adrenergic receptor antagonists accelerate skin wound healing: evidence for a catecholamine synthesis network in the epidermis. J Biol Chem 2006b;281:21225-35. (Pubitemid 44115462)
36. Pullar CE, Le Provost GS, O'Leary AP, Evans SE, Baier BS, Isseroff RR. Beta2AR antagonists and beta2AR gene deletion both promote skin wound repair processes. J Invest Dermatol 2012;132:2076-84.
37. Reid FM, GrahamJ, Niemuth NA, Singer AW, Janny SJ, Johnson JB. Sulfurmustard-induced skin burns in weanling swine evaluated clinically and histopathologically. J Appl Toxicol 2000;20(Suppl. 1):S153-60.
38. Reidy JJ, Zarzour J, Thompson HW, Beuerman RW. Effect of topical beta blockers on corneal epithelial wound healing in the rabbit. Br J Ophthalmol 1994;78:377-80. (Pubitemid 24167990)
39. Rogenski NM, Santos VL. Incidence of pressure ulcers at a university hospital. Rev Lat Am Enfermagem 2005;13:474-80.
40. Romana-Souza B, Nascimento AP, Monte-Alto-Costa A. Low-dose propranolol improves cutaneouswound healing of burn-injured rats. Plast Reconstr Surg 2008;122:1690-9.
41. Romana-Souza B, Santos JS, Monte-Alto-Costa A. Beta-1 and beta-2, but not alpha-1 and alpha-2, adrenoceptor blockade delays rat cutaneous wound healing. Wound Repair Regen 2009a;17:230-9.
42. Romana-Souza B, Santos JS, Desmouliere A, Monte-Alto-Costa A. Beta-adrenoceptor blockade delays granulation tissue formation in polyurethane sponge implants. J Cutan Pathol 2009b;36:522-8.
43. Romana-Souza B, Nascimento AP, Monte-Alto-Costa A. Propranolol improves cutaneous wound healing in streptozotocin-induced diabetic rats. Eur J Pharmacol 2009c;611:77-84.
44. Romana-Souza B, Porto LC, Monte-Alto-Costa A. Cutaneous wound healing of chronically stressed mice is improved through catecholamines blockade. Exp Dermatol 2010a;19:821-9.
45. Romana-Souza B, Otranto M, Vieira AM, Filgueiras CC, Fierro IM, Monte-Alto-Costa A. Rotational stress-induced increase in epinephrine levels delays cutaneous wound healing in mice. Brain Behav Immun 2010b;24:427-37.
46. Saint-Jean M, Leaute-Labreze C, Mazereeuw-Hautier J, Bodak N, Hamel-Teillac D, Kupfer-Bessaguet I, et al. Propranolol for treatment of ulcerated infantile hemangiomas. J Am Acad Dermatol 2011;64:827-32.
47. Saito Y, Hasegawa M, Fujimoto M, Matsushita T, Horikawa M, Takenaka M, et al. The loss of MCP-1 attenuates cutaneous ischemia -reperfusion injury in a mouse model of pressure ulcer. J Invest Dermatol 2008;128:1838-51. (Pubitemid 351847384)
48. Salcido R, Fisher SB, Donofrio JC, BieschkeM, Knapp C, Liang R, et al. An animal model and computer-controlled surface pressure delivery system for the production of pressure ulcers. J Rehabil Res Dev 1995;32:149-61.
49. Salcido R, Popescu A, Ahn C. Animal models in pressure ulcer research. J Spinal Cord Med 2007;30:107-16. (Pubitemid 46942225)
50. Schaeffer P, Bernat A, Arnone M, Manara L, Gallas JF, Dol-Gleizes F, et al. Effect of SR58611A, a potent beta-3 adrenoceptor agonist, on cutaneous wound healing in diabetic and obese mice. Eur J Pharmacol 2006;529:172-8. (Pubitemid 43005300)
51. Sivamani RK, Pullar CE,Manabat-Hidalgo CG, Rocke DM, Carlsen RC, Greenhalgh DG, et al. Stress-mediated increases in systemic and local epinephrine impair skin wound healing: potential new indication for beta blockers. PLoS Med 2009;6:105-15.
52. Souza BR, Santos JS, Costa AM. Blockade of beta1- and beta2-adrenoceptors delays wound contraction and re-epithelialization in rats. Clin Exp Pharmacol Physiol 2006;33:421-30.
53. Stadler I, Zhang RY, Oskoui P,WhittakerMS, Lanzafame RJ. Development of a simple, non-invasive, clinically relevant model of pressure ulcers in the mouse. J Invest Surg 2004;17:221-7. (Pubitemid 39172992)
54. Tscharntke M, Pofahl R, Chrostek-Grashoff A, Smyth N, Niessen C, Niemann C, et al. Impaired epidermal wound healing in vivo upon inhibition or deletion of Rac1. J Cell Sci 2007;120:1480-90. (Pubitemid 46780040)
55. Tsuji S, Ichioka S, Sekiya N, Nakatsuka T. Analysis of ischemia-reperfusion injury in a microcirculatory model of pressure ulcers. Wound Repair Regen 2005;13:209-15. (Pubitemid 40489872)
56. Usui ML, Mansbridge JN, Carter WG, Fujita M, Olerud JE. Keratinocyte migration, proliferation, and differentiation in chronic ulcers from patients with diabetes and normal wounds. J Histochem Cytochem 2008;56:687-96. (Pubitemid 351842422)
57. Wallukat G. The beta-adrenergic receptors. Herz 2002;27:683-90.
58. Woessner JF. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 1961;93:440-7.
59. Xu G, Lv R, Zhao Z, Huo R. Topical propranolol for treatment of superficial infantile hemangiomas. J Am Acad Dermatol 2012;67:1210-3.
60. Yager DR, Zhang LY, Liang HX, Diegelmann RF, Cohen IK. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol 1996;107:743-8. (Pubitemid 26371092)